Skip To Main Content
Rhys Brady on Muck Rack

Rhys Brady

London
As seen in: SAGE Publishing, Mary Ann Liebert, Inc.
Covers:  Gong Bath Training, Sound Bath Meditation London, Gong Meditation London

Get in touch with Rhys

Contact Rhys, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Rhys Brady’s Biography

Read Full Bio →

gong bath training,
sound bath meditation london,
gong meditation london,
gong bath,
sound bath,
gong meditation,
gong therapy

Rhys Brady’s Journalist Portfolio

Gong Bath Training

Gong Bath Training

Choose Leo Cosendai - Sound Bath for a premium gong bath training session that extends up to six months. This…

View article →

Articles

Treatment with the vascular endothelial growth factor-A antibody, bevacizumab, has sex-specific effects in a rat model of mild traumatic brain injury

|
By Mujun Sun, Tamara Baker, Campbell Wilson, Rhys Brady
| SAGE Publishing
Introduction Mild traumatic brain injury (mTBI) has an estimated annual incidence of 64–74 million worldwide.1 mTBI often results in debilitating short-term symptoms, and there is evidence that >50% of mTBI patients experience persisting symptoms for months to years after the injury.2–4 mTBI is also a risk factor for the later development of neurodegenerative conditions such as dementia,5 Parkinson’s disease,6 and chronic traumatic encephalopathy.7 Despite the high incidence of mTBI and risk...
Open in Who Shared Issue with article?

Activation of the Protein Kinase R-Like Endoplasmic Reticulum Kinase (PERK) Pathway of the Unfolded Protein Response after Experimental Traumatic Brain Injury and Treatment with a PERK Inhibitor | Neurotrauma Reports

|
By Rhys Brady, Mujun Sun, Glenn R. Yamakawa, Stefanie Bird
| Mary Ann Liebert, Inc.
Introduction Traumatic brain injury (TBI) is induced by mechanical forces applied to the brain and is a common consequence of vehicular accidents, slips/falls, assaults, as well as work-, sport-, and military-related injuries.1 It is a leading cause of death and disability worldwide, and there is currently no effective treatment known to mitigate the neurodegenerative aftermath that occurs in TBI survivors.1 Studies have identified the misfolding of several proteins in the outcomes of TBI.2–9...
Open in Who Shared Issue with article?
See all 2 articles